Providing Our Clients With the Best Products
Company Information
HymonBio Co., Ltd. was established in 2015, focusing on the development, production, and sale of precision medicine and molecular diagnostic products. Since its establishment in Taicang Port, HymonBio has applied for 58 patents, 3 PCT international patents, and obtained 18 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained EU CE; and 1 product has obtained an US FDA EUA. The company has also received the ISO13485 system certificate.
They have also won awards and honors, such as the CACLP National Gold Award, first prize in the "Lixing Cup" Global Innovation and Entrepreneurship Competition, becoming a business case selected for the National International Business Demonstration Case Library, and winning the “Golden Screening Award” at the World Cancer Early Screening Conference. HymonBio has also completed the first round of financing from PerkinElmer Ventures, a leading company in the IVD industry and also the latter’s first overseas investment project.
Our Focus
Expanding access to cancer diagnosis and pathogen detection with our PCR kits.
Our Model
Cooperate with institutions to expand our distribution network and products to make test kits more accessible.
Our Slogan
There is no sudden "onset" of cancer, only sudden "detection."
Team Leaders
Tan Miao / Founder and CEO
> She has received her PhD from the Chinese Academy of Sciences in 2006 and was a visiting professor at Max Planck Institute in Germany from 2005 to 2006. Since then, she has become a supervisor for Masters' Degree Students at Nanjing University, Southeast University, and Yan'an University.
> She had previously served as the R&D project manager of IVD-listed companies and was responsible for team management and was a member of the Medical Laboratory Expert Committee of the National Health Industry Management Association. Some of her achievements include: published 4 SCI papers in international journals; created 3 patented technologies; acknowledged as a doctor of Jiangsu Province Entrepreneurship and Innovation in 2016; and acknowledged as a Suzhou Leading Talent in 2017.
Ma Xiaojuan/GM
> Project Director and co-founder of of HymonBio. She received her Master's degree from Yangzhou University in 2005. Currently focuses on the development and promotion of molecular diagnostics products.
> She has more than 10 years of experience in the IVD industry; previously served as R&D manager of listed companies; previously served as quality control manager for foreign enterprises; and assistant director of sales and marketing.